scholarly journals Where can you wear your libre? Using the FreeStyle Libre Continuous Glucose Monitor on Alternative Sites

Author(s):  
Rosemary M Hall ◽  
Sophie Dyhrberg ◽  
Arthur McTavish ◽  
Lindsay McTavish ◽  
Brian Corley ◽  
...  
2019 ◽  
Vol 20 (8) ◽  
pp. 1072-1079 ◽  
Author(s):  
Nejla Ghane ◽  
Miranda M. Broadney ◽  
Elisabeth K. Davis ◽  
Robert W. Trenschel ◽  
Shavonne M. Collins ◽  
...  

2019 ◽  
Vol 13 (5) ◽  
pp. 963-966 ◽  
Author(s):  
Kathryn Fantasia ◽  
Katherine Modzelewski ◽  
Devin Steenkamp

In this commentary, we briefly review the currently recommended approaches to interpretation and management of continuous glucose monitor (CGM) rate of change (ROC) trend arrows and discuss the inherent difficulty in incorporating practical recommendations for their application into routine clinical care. We have limited our review and discussion to the currently available Dexcom G5 and G6 CGM systems and Abbott’s Freestyle Libre flash glucose monitor (FGM) system, as they are the most widely used and currently approved for nonadjunctive use in the United States.


2021 ◽  
Vol 6 (1) ◽  
pp. 58
Author(s):  
Lauriane Bertrand ◽  
Nathan Cleyet-Marrel ◽  
Zilu Liang

The study of eating behavior has become increasingly important due to the alarming high prevalence of lifestyle-related chronic diseases. In this study, we investigated the feasibility of automatic detection of eating events using affordable consumer wearable devices, including Fitbit wristbands, Mi Bands, and the FreeStyle Libre continuous glucose monitor (CGM). Random forest and XGBoost were applied to develop binary classifiers for distinguishing eating and non-eating events. Our results showed that the proposed method can recognize eating events with an average sensitivity of up to 71%. The classifier using random forest with SMOTE resampling exhibited the best overall performance.


2019 ◽  
Vol 14 (5) ◽  
pp. 844-853 ◽  
Author(s):  
Mona Elbalshy ◽  
Sara Boucher ◽  
Hamish Crocket ◽  
Barbara Galland ◽  
Craig MacKenzie ◽  
...  

Background: MiaoMiao (MM) is a Bluetooth transmitter, which when paired with a smart phone/device, converts the Abbott FreeStyle Libre flash glucose monitoring system into a Do-It-Yourself (DIY) continuous glucose monitor (CGM). Families are increasingly adopting DIY CGM solutions, but little is known about parent and child experiences with these add-on technologies. We aimed to explore experiences of families using MM-CGM including challenges faced and their advice to others who may choose to use the technology. Methods: Between May and July 2019, we conducted 12 semistructured interviews (in person or via video conference) with parents of children (aged ≤16 years) with type 1 diabetes using MM-CGM. Interviews were audio recorded; professionally transcribed and key themes were identified through thematic analysis. Results: Overall, parents used MM-CGM to proactively manage their child’s blood glucose. In all participants, this led to a perceived decrease in frequency of hypoglycemia. Participants reported that the visibility and easy access to blood glucose readings, glucose trends, and customized alarms on parent’s phones decreased their disease burden and improved their sleep quality. Common barriers to using MM-CGM included difficulty of the setting up process, connectivity issues, and lack of support from medical teams. Conclusion: This study highlights the potential feasibility of using a DIY CGM system like MM-CGM, which could be an empowering and cost-effective tool for enabling remote monitoring of blood glucose in real time.


2020 ◽  
pp. 193229682096700
Author(s):  
Tejaswi Kompala ◽  
Aaron B. Neinstein

In this study by Alva et al, accuracy of a second-generation factory calibrated continuous glucose monitoring system is evaluated. Compared to the first-generation FreeStyle Libre 14-day system (FSL), accuracy was improved throughout the 14-day wear period, including improved accuracy in hypoglycemia for adults and youth. The addition of optional real-time alerts for hypoglycemia and hyperglycemia as well as an integrated continuous glucose monitor (iCGM) designation by the FDA may further enable users to benefit from using CGM in real time, including in future automated insulin delivery systems. As CGM accuracy, affordability, and accessibility improve, we anticipate increased uptake of CGM by people on intensive insulin therapy, and also potential benefits and expansion into a broader patient population. There are growing opportunities to leverage cloud-connected CGM devices in the increasingly virtual, continuous telehealth-driven diabetes care model, which will require more focus on development and use of data interoperability standards.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1017-P ◽  
Author(s):  
JANET K. SNELL-BERGEON ◽  
HALIS K. AKTURK ◽  
AMANDA REWERS ◽  
BRUCE W. BODE ◽  
LESLIE J. KLAFF ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document